The prevalence of asymptomatic pancreatic cysts is increasing due to advances in imaging techniques. Among these, intraductal papillary mucinous neoplasms (IPMNs) are most common, with potential for malignant transformation, often necessitating close follow-up. This study evaluates novel MRI techniques for the assessment of IPMN. From May to December 2023, 59 patients undergoing abdominal MRI were retrospectively enrolled. Examinations were conducted on 3-Tesla scanners using a Deep-Learning Accelerated Half-Fourier Single-Shot Turbo Spin-Echo (HASTE_DL) and standard HASTE (HASTE_S) sequence. Two readers assessed minimum detectable lesion size and lesion-to-parenchyma contrast quantitatively, and qualitative assessments focused on image quality. Statistical analyses included the Wilcoxon signed-rank and chi-squared tests. HASTE_DL demonstrated superior overall image quality (p < 0.001), with higher sharpness and contrast ratings (p < 0.001, p = 0.112). HASTE_DL showed enhanced conspicuity of IPMN (p < 0.001) and lymph nodes (p < 0.001), with more frequent visualization of IPMN communication with the pancreatic duct (p < 0.001). Visualization of complex features (dilated pancreatic duct, septa, and mural nodules) was superior in HASTE_DL (p < 0.001). The minimum detectable cyst size was significantly smaller for HASTE_DL (4.17 mm ± 3.00 vs. 5.51 mm ± 4.75; p < 0.001). Inter-reader agreement was for (к 0.936) for HASTE_DL, slightly lower (к 0.885) for HASTE_S. HASTE_DL in IPMN imaging provides superior image quality and significantly reduced scan times. Given the increasing prevalence of IPMN and the ensuing clinical need for fast and precise imaging, HASTE_DL improves the availability and quality of patient care. Question Are there advantages of deep-learning-accelerated MRI in imaging and assessing intraductal papillary mucinous neoplasms (IPMN)? Findings Deep-Learning Accelerated Half-Fourier Single-Shot Turbo Spin-Echo (HASTE_DL) demonstrated superior image quality, improved conspicuity of "worrisome features" and detection of smaller cysts, with significantly reduced scan times. Clinical relevance HASTEDL provides faster, high-quality MRI imaging, enabling improved diagnostic accuracy and timely risk stratification for IPMN, potentially enhancing patient care and addressing the growing clinical demand for efficient imaging of IPMN.

Detecting malignant transformation of sinonasal inverted papilloma (SIP) into squamous cell carcinoma (SIP-SCC) before surgery is a clinical need. We aimed to explore the value of deep learning (DL) that leverages nasal endoscopy and T2-weighted magnetic resonance imaging (T2W-MRI) for automated tumor segmentation and differentiation between SIP and SIP-SCC. We conducted a retrospective analysis of 174 patients diagnosed with SIPs, who were divided into a training cohort (n = 121) and a testing cohort (n = 53). Three DL architectures were utilized to train automated segmentation models for endoscopic and T2W-MRI images. DL scores predicting SIP-SCC were generated using DenseNet121 from both modalities and combined to create a dual-modality DL nomogram. The diagnostic performance of the DL models was assessed alongside two radiologists, evaluated through the area under the receiver operating characteristic curve (AUROC), with comparisons made using the Delong method. In the testing cohort, the FCN_ResNet101 and VNet exhibited superior performance in automated segmentation, achieving mean dice similarity coefficients of 0.95 ± 0.03 for endoscopy and 0.93 ± 0.02 for T2W-MRI, respectively. The dual-modality DL nomogram based on automated segmentation demonstrated the highest predictive performance for SIP-SCC (AUROC 0.865), outperforming the radiology resident (AUROC 0.672, p = 0.071) and the attending radiologist (AUROC 0.707, p = 0.066), with a trend toward significance. Notably, both radiologists improved their diagnostic performance with the assistance of the DL nomogram (AUROCs 0.734 and 0.834). The DL framework integrating endoscopy and T2W-MRI offers a fully automated predictive tool for SIP-SCC. The integration of endoscopy and T2W-MRI within a well-established DL framework enables fully automated prediction of SIP-SSC, potentially improving decision-making for patients with suspicious SIP. Detecting the transformation of SIP into SIP-SCC before surgery is both critical and challenging. Endoscopy and T2W-MRI were integrated using DL for predicting SIP-SCC. The dual-modality DL nomogram outperformed two radiologists. The nomogram may improve decision-making for patients with suspicious SIP.

To construct an artificial intelligence (AI)-assisted model for identifying the infraorbital posterior ethmoid cells (IPECs) based on deep learning using sagittal CT images. Sagittal CT images of 277 samples with and 142 samples without IPECs were retrospectively collected. An experienced radiologist engaged in the relevant aspects picked a sagittal CT image that best showed IPECs. The images were randomly assigned to the training and test sets, with 541 sides in the training set and 97 sides in the test set. The training set was used to perform a five-fold cross-validation, and the results of each fold were used to predict the test set. The model was built using nnUNet, and its performance was evaluated using Dice and standard classification metrics. The model achieved a Dice coefficient of 0.900 in the training set and 0.891 in the additional set. Precision was 0.965 for the training set and 1.000 for the additional set, while sensitivity was 0.981 and 0.967, respectively. A comparison of the diagnostic efficacy between manual outlining by a less-experienced radiologist and AI-assisted outlining showed a significant improvement in detection efficiency (P < 0.05). The AI model aided correctly in identifying and outlining all IPECs, including 12 sides that the radiologist should improve portraying. AI models can help radiologists identify the IPECs, which can further prompt relevant clinical interventions.

To compare the quality of AI-ADC maps and standard ADC maps in a multi-reader study. Multi-reader study included 74 consecutive patients (median age = 66 years, [IQR = 57.25-71.75 years]; median PSA = 4.30 ng/mL [IQR = 1.33-7.75 ng/mL]) with suspected or confirmed PCa, who underwent mpMRI between October 2023 and January 2024. The study was conducted in two rounds, separated by a 4-week wash-out period. In each round, four readers evaluated T2W-MRI and standard or AI-generated ADC (AI-ADC) maps. Fleiss' kappa, quadratic-weighted Cohen's kappa statistics were used to assess inter-reader agreement. Linear mixed effect models were employed to compare the quality evaluation of standard versus AI-ADC maps. AI-ADC maps exhibited significantly enhanced imaging quality compared to standard ADC maps with higher ratings in windowing ease (β = 0.67 [95% CI 0.30-1.04], p < 0.05), prostate boundary delineation (β = 1.38 [95% CI 1.03-1.73], p < 0.001), reductions in distortion (β = 1.68 [95% CI 1.30-2.05], p < 0.001), noise (β = 0.56 [95% CI 0.24-0.88], p < 0.001). AI-ADC maps reduced reacquisition requirements for all readers (β = 2.23 [95% CI 1.69-2.76], p < 0.001), supporting potential workflow efficiency gains. No differences were observed between AI-ADC and standard ADC maps' inter-reader agreement. Our multi-reader study demonstrated that AI-ADC maps improved prostate boundary delineation, had lower image noise, fewer distortions, and higher overall image quality compared to ADC maps. Question Can we synthesize apparent diffusion coefficient (ADC) maps with AI to achieve higher quality maps? Findings On average, readers rated quality factors of AI-ADC maps higher than ADC maps in 34.80% of cases, compared to 5.07% for ADC (p < 0.01). Clinical relevance AI-ADC maps may serve as a reliable diagnostic support tool thanks to their high quality, particularly when the acquired ADC maps include artifacts.

The specific role of lysophospholipids (LysoPLs) in the pathogenesis of chronic obstructive pulmonary disease (COPD) is not yet fully understood. We determined serum LysoPLs in 20 patients with stable COPD and 20 healthy smokers using liquid chromatography-mass spectrometry (LC-MS) and matching with the lipidIMMS library, and integrated these data with spirometry, systemic inflammation markers, and quantitative chest CT generated by an automated 3D-U-Net artificial intelligence algorithm model. Our findings identified three differential LysoPLs, lysophosphatidylcholine (LPC) (18:0), LPC (18:1), and LPC (18:2), which were significantly lower in the COPD group than in healthy smokers. Significant negative correlations were observed between these LPCs and the inflammatory markers C-reactive protein and Interleukin-6. LPC (18:0) and (18:2) correlated with higher post-bronchodilator FEV1, and the latter also correlated with FEV1% predicted, forced vital capacity (FVC), and FEV1/FVC ratio. Additionally, these three LPCs were negatively correlated with the volume and percentage of low attenuation areas (LAA), high-attenuation areas (HAA), honeycombing, reticular patterns, ground-glass opacities (GGO), and consolidation on CT imaging. In the patients with COPD, the three LPCs were most significantly associated with HAA and GGO. In conclusion, patients with stable COPD exhibited a unique LysoPL metabolism profile, with LPC (18:0), LPC (18:1), and LPC (18:2) being the most significantly altered lipid molecules. The reduction in these three LPCs was associated with impaired pulmonary function and were also linked to a greater extent of emphysema and interstitial lung abnormalities.

Small animal models are crucial for investigating idiopathic pulmonary fibrosis (IPF) and developing preclinical therapeutic strategies. However, there are several limitations to the quantitative measurements used in the longitudinal assessment of experimental lung fibrosis, e.g., histological or biochemical analyses introduce inter-individual variability, while image-derived biomarker has yet to directly and accurately quantify the severity of lung fibrosis. This study investigates artificial intelligence (AI)-assisted, end-to-end, semi-quantitative measurement of lung fibrosis using in vivo micro-CT. Based on the bleomycin (BLM)-induced lung fibrosis mouse model, the AI model predicts histopathological scores from in vivo micro-CT images, directly correlating these images with the severity of lung fibrosis in mice. Fibrosis severity was graded by the Ashcroft scale: none (0), mild (1-3), moderate (4-5), severe (≥6).The overall accuracy, precision, recall, and F1 scores of the lung fibrosis severity-stratified 3-fold cross validation on 225 micro-CT images for the proposed AI model were 92.9%, 90.9%, 91.6%, and 91.0%. The overall area under the receiver operating characteristic curve (AUROC) was 0.990 (95% CI: 0.977, 1.000), with AUROC values of 1.000 for none (100 images, 95% CI: 0.997, 1.000), 0.969 for mild (43 images, 95% CI: 0.918, 1.000), 0.992 for moderate (36 images, 95% CI: 0.962, 1.000), and 0.992 for severe (46 images, 95% CI: 0.967, 1.000). Preliminary results indicate that AI-assisted, in vivo micro-CT-based semi-quantitative measurements of murine are feasible and likely accurate. This novel method holds promise as a tool to improve the reproducibility of experimental studies in animal models of IPF.

The aim of this study was to evaluate the benefit of a volumetric AI-based body composition analysis (BCA) algorithm in multiple myeloma (MM). Therefore, a retrospective monocentric cohort of 91 MM patients was analyzed. The BCA algorithm, powered by a convolutional neural network, quantified tissue compartments and bone density based on routine CT scans. Correlations between BCA data and demographic/clinical parameters were investigated. BCA-endotypes were identified and survival rates were compared between BCA-derived patient clusters. Patients with high-risk cytogenetics exhibited elevated cardiac marker index values. Across Revised-International Staging System (R-ISS) categories, BCA parameters did not show significant differences. However, both subcutaneous and total adipose tissue volumes were significantly lower in patients with progressive disease or death during follow-up compared to patients without progression. Cluster analysis revealed two distinct BCA-endotypes, with one group displaying significantly better survival. Furthermore, a combined model composed of clinical parameters and BCA data demonstrated a higher predictive capability for disease progression compared to models based solely on high-risk cytogenetics or R-ISS. These findings underscore the potential of BCA to improve patient stratification and refining prognostic models in MM.

The decision to treat unruptured intracranial aneurysms remains a clinical dilemma. Middle cerebral artery (MCA) aneurysms represent a prevalent subtype of intracranial aneurysms. This study aims to develop a multimodal fusion deep learning model for stratifying rupture risk in MCA aneurysms. We retrospectively enrolled internal cohort and two external validation datasets with 578 and 51 MCA aneurysms, respectively. Multivariate logistic regression analysis was performed to identify independent predictors of rupture. Aneurysm morphological parameters were quantified using reconstructed CT angiography (CTA) images. Radiomics features of aneurysms were extracted through computational analysis. We developed MCANet - a multimodal data-driven classification model integrating raw CTA images, radiomics features, clinical parameters, and morphological characteristics - to establish an aneurysm rupture risk assessment framework. External validation was conducted using datasets from two independent medical centers to evaluate model generalizability and small-sample robustness. Four key metrics, including accuracy, F1-score, precision, and recall, were employed to assess model performance. In the internal cohort, 369 aneurysms were ruptured. Independent predictors of rupture included: the presence of multiple aneurysms, aneurysm location, aneurysm angle, presence of daughter-sac aneurysm, and height-width ratio. MCANet demonstrated satisfactory predictive performance with 91.38% accuracy, 96.33% sensitivity, 90.52% precision, and 93.33% F1-score. External validation maintained good discriminative ability across both independent cohorts. The MCANet model effectively integrates multimodal heterogeneous data for MCA aneurysm rupture risk prediction, demonstrating clinical applicability even in data-constrained scenarios. This model shows potential to optimize therapeutic decision-making and mitigate patient anxiety through individualized risk assessment.

Pulmonary nodules are critical indicators for the early detection of lung cancer; however, their diagnosis and management pose significant challenges due to the variability in nodule characteristics, reader fatigue, and limited clinical expertise, often leading to diagnostic errors. The rapid advancement of artificial intelligence (AI) presents promising solutions to address these issues. This review compares traditional rule-based methods, handcrafted feature-based machine learning, radiomics, deep learning, and hybrid models incorporating Transformers or attention mechanisms. It systematically compares their methodologies, clinical applications (diagnosis, treatment, prognosis), and dataset usage to evaluate performance, applicability, and limitations in pulmonary nodule management. AI advances have significantly improved pulmonary nodule management, with transformer-based models achieving leading accuracy in segmentation, classification, and subtyping. The fusion of multimodal imaging CT, PET, and MRI further enhances diagnostic precision. Additionally, AI aids treatment planning and prognosis prediction by integrating radiomics with clinical data. Despite these advances, challenges remain, including domain shift, high computational demands, limited interpretability, and variability across multi-center datasets. Artificial intelligence (AI) has transformative potential in improving the diagnosis and treatment of lung nodules, especially in improving the accuracy of lung cancer treatment and patient prognosis, where significant progress has been made.

Autism Spectrum Disorder (ASD) is a complex neurodevelopmental condition with heterogeneous symptomatology, making accurate diagnosis challenging. Traditional methods rely on subjective behavioral assessments, often overlooking subtle neural biomarkers. This study introduces ASD-GraphNet, a novel graph-based learning framework for diagnosing ASD using functional Magnetic Resonance Imaging (fMRI) data. Leveraging the Autism Brain Imaging Data Exchange (ABIDE) dataset, ASD-GraphNet constructs brain networks based on established atlases (Craddock 200, AAL, and Dosenbach 160) to capture intricate connectivity patterns. The framework employs systematic preprocessing, graph construction, and advanced feature extraction to derive node-level, edge-level, and graph-level metrics. Feature engineering techniques, including Mutual Information-based selection and Principal Component Analysis (PCA), are applied to enhance classification performance. ASD-GraphNet evaluates a range of classifiers, including Logistic Regression, Support Vector Machines, and ensemble methods like XGBoost and LightGBM, achieving an accuracy of 75.25% in distinguishing individuals with ASD from healthy controls. This demonstrates the framework's potential to provide objective, data-driven diagnostics based solely on resting-state fMRI data. By integrating graph-based learning with neuroimaging and addressing dataset imbalance, ASD-GraphNet offers a scalable and interpretable solution for early ASD detection, paving the way for more reliable interventions. The GitHub repository for this project is available at: https://github.com/AmirDavoodi/ASD-GraphNet.